Atos Stock: Shares Drop to €41.90, Hitting a Historically Low RSI
Atos shares fell by 2.5% this Tuesday morning, settling at €41.90 and extending a downward trend that began several sessions ago. The stock has now declined by more than 15% over seven days, amid technical indicators signaling strong selling pressure. However, two recent business updates shed light on the operational positioning of the group.
Technical Indicators Highlight Bearish Momentum
Atos' stock price is now trading below its 200-day moving average, which stands at €43.72 and previously acted as a technical support zone. This downward breach occurs as the stock also trades well below its 50-day moving average (€51.76), confirming a downward trend. The RSI, an indicator measuring the velocity of price changes, has dropped to 12, a level considered highly oversold and rarely seen for this stock. This extreme threshold reflects the intensity of the recent bearish movement, which has pushed the three-month performance into negative territory at -5.26%, despite a still significant annual gain of 55.19%. The next identifiable technical support is around €42.98, corresponding to the previous day's price, while resistance is significantly higher, at €60.20.
Operational Developments Strengthen Market Position
On the operational front, Eviden, the group's product division, announced this Tuesday the deployment of its ARPEGE system during a NATO Tactical Leadership Program exercise held in Spain last November. This radar threat simulator, used by the French forces since 2022 for fighter pilot training, confirms Eviden's place within the European defense ecosystem. Furthermore, the group has been recognized as a leader in public multi-cloud services in France by the ISG Provider Lens for the year 2025. This accolade is based on strategic alliances formed with major global cloud infrastructure providers and the integration of artificial intelligence into the service offering. These two announcements come less than three weeks before the publication of the annual results for 2025, scheduled for March 6, a deadline that could be a crucial catalyst for the stock's trajectory.
